Mallinckrodt reports $2.29 million loss for February period

By Sarah Lizee

Olympia, Wash., March 22 – Mallinckrodt plc reported a $2.29 million loss on zero gross income/sales for the Jan. 29 through March 4 period, according to its monthly operating report filed Monday with the U.S. Bankruptcy Court for the District of Delaware.

The company had a $10.81 million cash balance at the end of the period.

Dublin-based Mallinckrodt develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. The company filed Chapter 11 bankruptcy on Oct. 12, 2020 under case number 20-12522.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.